| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 665364 | 61617 | ADOLONTA 100 mg/ ml SOLUCION ORAL | ADOLONTA 100 mg/ ml SOLUCION ORAL , 1 frasco de 30 ml | 100 mg/ml | 6 | 30 | 26 | 1 frasco de 30 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61617/61617_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61617/61617_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10103 | GRÜNENTHAL PHARMA S.A. | 1998-02-01 | 1 | 1 | 1 | 1998-02-01 | 1998-02-01 | 1 | 2011-10-13 | View Edit Delete | ||||||||||||
| 664153 | 71576 | VIGAMOX 5 mg/ml COLIRIO EN SOLUCION | VIGAMOX 5 mg/ml COLIRIO EN SOLUCION , 1 frasco de 5 ml | 5 mg/ml | 6 | 5 | 26 | 1 frasco de 5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/71576/71576_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/71576/71576_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1945 | NOVARTIS FARMACEUTICA S.A. | 2009-10-26 | 1 | 1 | 1 | 2009-10-26 | 2009-10-26 | 1 | 2011-11-08 | View Edit Delete | ||||||||||||
| 664929 | 72005 | SEHCAT 370 KBQ CAPSULAS | SEHCAT 370 KBQ CAPSULAS, 1 cápsula | 370 kBq | 6 | 1 | 43 | 1 cápsula | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72005/72005_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72005/72005_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 10603 | GE HEALTHCARE BIO-SCIENCES, S.A.U. | 2010-03-24 | 1 | 1 | 1 | 2010-03-24 | 2010-03-24 | 1 | 2011-10-10 | View Edit Delete | ||||||||||||
| 663822 | 71356 | CUVENAX 35 microgramos/PULSACION SOLUCION PARA PULVERIZACION NASAL | CUVENAX 35 microgramos/PULSACION SOLUCION PARA PULVERIZACION NASAL, 1 frasco de 15 ml | 0,5 mg/ml | 6 | 15 | 26 | 1 frasco de 15 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/71356/71356_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/71356/71356_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23862 | PHARMEX ADVANCED LABORATORIES S.L. | 2009-08-31 | 1 | 1 | 1 | 2018-07-19 | 2018-07-19 | 1 | 2018-10-18 | View Edit Delete | ||||||||||||
| 664347 | 56811 | RESPIBIEN ANTIALERGICO SOLUCION PARA PULVERIZACION NASAL | RESPIBIEN ANTIALERGICO SOLUCION PARA PULVERIZACION NASAL, 1 envase pulverizador de 15 ml | 0,5 mg/ml + 0,5 mg/ml | 6 | 15 | 26 | 1 envase pulverizador de 15 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/56811/56811_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/56811/56811_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 1989-02-01 | 1 | 1 | 1 | 1989-02-01 | 2010-03-15 | 1 | 2011-10-19 | View Edit Delete | ||||||||||||
| 664496 | 71816 | RIVASTIGMINA CINFA 2 mg/ml SOLUCION ORAL EFG | RIVASTIGMINA CINFA 2 mg/ml SOLUCION ORAL EFG , 1 frasco de 120 ml con jeringa dosificadora | 2 mg/ml | 6 | 120 | 26 | 1 frasco de 120 ml, con jeringa dosificadora | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/71816/71816_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/71816/71816_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2010-01-14 | 1 | 1 | 1 | 2010-01-14 | 2010-01-14 | 1 | 2011-10-19 | View Edit Delete | ||||||||||||
| 664267 | 68004 | APIROFENO 40 mg/ml SUSPENSION ORAL | APIROFENO 40 mg/ml SUSPENSION ORAL , 1 frasco de 50 ml | 40 mg/ml | 6 | 50 | 26 | 1 frasco de 50 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68004/68004_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68004/68004_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 945 | LABORATORIOS ERN S.A. | 2006-08-29 | 1 | 1 | 1 | 2006-08-29 | 2009-11-19 | 1 | 2011-09-09 | View Edit Delete | ||||||||||||
| 664683 | 71639 | MASTICAL D UNIDIA 1000 MG/800 UI COMPRIMIDOS MASTICABLES | MASTICAL D UNIDIA 1000 MG/800 UI COMPRIMIDOS MASTICABLES, 30 comprimidos | 2.500 mg (1.000 mg Ca)/800 UI | 6 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/71639/71639_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/71639/71639_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 25535 | LABORATORIOS RUBIO S.A. | 2010-02-02 | 1 | 1 | 1 | 2010-02-02 | 2010-02-02 | 1 | 2011-09-13 | View Edit Delete | ||||||||||||
| 663756 | 66954 | MINOXIDIL VIÑAS 50 mg/ml SOLUCION CUTANEA | MINOXIDIL VIÑAS 50 mg/ml SOLUCION CUTANEA, 3 frascos de 60 ml | 50 mg/ml | 6 | 180 | 26 | 3 frascos de 60 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/66954/66954_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/66954/66954_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3047 | LABORATORIOS VINAS S.A. | 2005-09-01 | 1 | 1 | 1 | 2005-09-01 | 2009-08-06 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 664148 | 71501 | OCTAGAMOCTA 100 mg/ml SOLUCION PARA PERFUSION | OCTAGAMOCTA 100 mg/ml SOLUCION PARA PERFUSION , 1 vial de 50 ml | 100 mg/ml inyectable 50 ml | 6 | 1 | 34 | 1 vial de 50 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/71501/71501_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/71501/71501_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 5237 | OCTAPHARMA S.A. | 2009-11-02 | 1 | 1 | 1 | 2009-11-02 | 2009-11-02 | 0 | 2011-06-02 | View Edit Delete | ||||||||||||
| 664149 | 71501 | OCTAGAMOCTA 100 mg/ml SOLUCION PARA PERFUSION | OCTAGAMOCTA 100 mg/ml SOLUCION PARA PERFUSION , 1 vial de 200 ml | 100 mg/ml inyectable 200 ml | 6 | 1 | 34 | 1 vial de 200 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/71501/71501_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/71501/71501_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 5237 | OCTAPHARMA S.A. | 2009-11-02 | 1 | 1 | 1 | 2009-11-02 | 2009-11-02 | 0 | 2011-06-02 | View Edit Delete | ||||||||||||
| 664150 | 71501 | OCTAGAMOCTA 100 mg/ml SOLUCION PARA PERFUSION | OCTAGAMOCTA 100 mg/ml SOLUCION PARA PERFUSION , 1 vial de 100 ml | 100 mg/ml inyectable 100 ml | 6 | 1 | 34 | 1 vial de 100 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/71501/71501_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/71501/71501_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 5237 | OCTAPHARMA S.A. | 2009-11-02 | 1 | 1 | 1 | 2009-11-02 | 2009-11-02 | 0 | 2011-06-02 | View Edit Delete | ||||||||||||
| 663821 | 71352 | NOVAG RINO 35 microgramos/PULSACION SOLUCION PARA PULVERIZACION NASAL | NOVAG RINO 35 microgramos/PULSACION SOLUCION PARA PULVERIZACION NASAL , 1 frasco de 15 ml | 0,5 mg/ml | 6 | 15 | 26 | 1 frasco de 15 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/71352/71352_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/71352/71352_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2876 | TARBIS FARMA S.L. | 2009-08-31 | 1 | 1 | 1 | 2009-08-31 | 2009-08-31 | 1 | 2012-06-20 | View Edit Delete | ||||||||||||
| 665381 | 72302 | PANTOPRAZOL TARBIS 20 mg COMPRIMIDOS GASTRORRESISTENTES EFG | PANTOPRAZOL TARBIS 20 mg COMPRIMIDOS GASTRORRESISTENTES EFG, 28 comprimidos (FRASCO) | 20 mg | 6 | 28 | 10 | 28 comprimidos (FRASCO) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72302/72302_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72302/72302_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2876 | TARBIS FARMA S.L. | 2010-05-26 | 1 | 1 | 1 | 2010-05-26 | 2010-05-26 | 1 | 2015-07-07 | View Edit Delete | ||||||||||||
| 665382 | 72300 | PANTOPRAZOL TARBIS 40 mg COMPRIMIDOS GASTRORRESISTENTES EFG | PANTOPRAZOL TARBIS 40 mg COMPRIMIDOS GASTRORRESISTENTES EFG, 28 comprimidos (FRASCO) | 40 mg | 6 | 28 | 10 | 28 comprimidos (FRASCO) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72300/72300_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72300/72300_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2876 | TARBIS FARMA S.L. | 2010-05-26 | 1 | 1 | 1 | 2010-05-26 | 2010-05-26 | 1 | 2015-07-07 | View Edit Delete | ||||||||||||
| 664259 | 71628 | NOTUS MUCOLÍTICO 50 MG/ML SOLUCIÓN ORAL | NOTUS MUCOLÍTICO 50 MG/ML SOLUCIÓN ORAL , 1 frasco de 200 ml | 50 mg/ml | 6 | 200 | 26 | 1 frasco de 200 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/71628/71628_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/71628/71628_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | TEVA PHARMA S.L.U. | 2009-11-16 | 1 | 1 | 1 | 2009-11-16 | 2009-11-16 | 1 | 2011-10-24 | View Edit Delete | ||||||||||||
| 665399 | 72299 | PANTOPRAZOL TEVA-RATIO 20 mg COMPRIMIDOS GASTRORRESISTENTES EFG | PANTOPRAZOL TEVA-RATIO 20 mg COMPRIMIDOS GASTRORRESISTENTES EFG, 28 comprimidos (FRASCO) | 20 mg | 6 | 28 | 10 | 28 comprimidos (FRASCO) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72299/72299_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72299/72299_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | TEVA PHARMA S.L.U. | 2010-05-26 | 1 | 1 | 1 | 2010-05-26 | 2010-05-26 | 1 | 2016-09-12 | View Edit Delete | ||||||||||||
| 665401 | 72298 | PANTOPRAZOL TEVA-RATIO 40 mg COMPRIMIDOS GASTRORRESISTENTES EFG | PANTOPRAZOL TEVA-RATIO 40 mg COMPRIMIDOS GASTRORRESISTENTES EFG, 28 comprimidos (FRASCO) | 40 mg | 6 | 28 | 10 | 28 comprimidos (FRASCO) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72298/72298_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72298/72298_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | TEVA PHARMA S.L.U. | 2010-05-26 | 1 | 1 | 1 | 2010-05-26 | 2010-05-26 | 1 | 2016-09-12 | View Edit Delete | ||||||||||||
| 664463 | 71778 | RIVASTIGMINA KERN PHARMA 2 mg/ml SOLUCION ORAL EFG | RIVASTIGMINA KERN PHARMA 2 mg/ml SOLUCION ORAL EFG , 1 frasco de 120 ml con jeringa dosificadora | 2 mg/ml | 6 | 120 | 26 | 1 frasco de 120 ml con jeringa dosificdora | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/71778/71778_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/71778/71778_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1534 | KERN PHARMA S.L. | 2009-12-16 | 1 | 1 | 1 | 2009-12-16 | 2009-12-16 | 1 | 2012-09-19 | View Edit Delete | ||||||||||||
| 664581 | 61846 | CLORXIL 10 mg/ml SOLUCION PARA PULVERIZACION CUTANEA | CLORXIL 10 mg/ml SOLUCION PARA PULVERIZACION CUTANEA, 1 frasco de 100 ml | 10 mg/ml | 6 | 100 | 26 | 1 frasco de 100 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61846/61846_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61846/61846_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 39653 | LABORATORIOS HARTMANN S.A. | 1998-07-01 | 1 | 1 | 1 | 1998-07-01 | 1998-07-01 | 0 | 2011-10-26 | View Edit Delete |
Page 217 of 1036, showing 20 records out of 20704 total, starting on record 4321, ending on 4340